Medical Tourism

Requires Standards 1–7 verified first

10 criteria

ALL YES Standard likely met. ANY PARTIAL Improvement plan required. ANY NO Blocks accreditation until resolved.

REFERENCES

1. [101] WHO's guidance on financial protection in health systems identifies advance cost transparency as a determinant of genuine informed consent, a principle that applies with particular force when the patient has limited ability to seek a second opinion or negotiate after arrival.

A patient who has already booked flights and arranged time away from home has far less power to question a cost surprise than a local patient would. All-inclusive, advance pricing isn't a courtesy in this context — it's the only point in the process where a foreign patient can still genuinely walk away.

1 Estimates are written and complete for the primary procedure but not for commonly bundled extras.

A patient comparing quotes needs the genuinely full picture, not just the headline procedure cost.

2 The estimate is provided in writing but only after initial travel arrangements are already underway.

The protective value of advance pricing depends on it arriving before the patient's negotiating position weakens.

3 A cost change process exists but isn't proactively explained to patients in advance.

A process patients don't know about doesn't provide real reassurance if a change occurs.

Week 1 Review current pricing communication practice against genuine advance, all-inclusive standard.

Week 2 Build a complete, written estimate template covering commonly needed extras.

Week 3 Establish a transparent process for communicating any genuine cost change.

Ongoing Audit final costs against original estimates for a sample of patients.

Ask a recent international patient directly whether the final cost matched the original quote.

This is the clearest, most direct test of genuine pricing transparency.

Ask to see a written estimate for a specific, real patient, not a generic template.

A real example reveals whether the practice is genuinely followed, not just documented in policy.

ALL YES Standard likely met. ANY PARTIAL Improvement plan required. ANY NO Blocks accreditation until resolved.

REFERENCES

1. [102] Continuity of care across international transitions is identified in cross-border healthcare literature as a distinct risk point, with incomplete or inaccessible record transfer directly linked to preventable post-return complications.

A patient who develops a complication after returning home depends entirely on their home provider having genuine, usable information about what was actually done — and the gap between records existing and records actually, usably reaching the right person is exactly where continuity of care most commonly and dangerously fails in medical tourism.

1 Handoff happens reliably when the home provider is known in advance but not when the patient hasn't identified one.

Even without a named home provider, the patient still needs usable records and a contact pathway.

2 Records are provided but not translated into a language the likely home provider would use.

Technically provided but practically unusable documentation doesn't achieve genuine continuity.

3 A contact pathway exists but isn't clearly communicated to the patient before they leave.

A pathway the patient doesn't know about functions the same as no pathway at all.

Week 1 Review current handoff practice for genuine completion versus theoretical availability.

Week 2 Establish a process for translating records into a usable language and format.

Week 3 Establish and clearly communicate a specific post-departure contact pathway.

Ongoing Confirm handoff completion for every international patient before departure.

Ask for a real, recent example of a completed handoff, not a description of the general process.

A real example reveals whether handoff genuinely happens, not just theoretically exists as a policy.

Ask a patient directly how they'd reach this facility if a problem developed after they returned home.

A confident, specific answer reveals whether the contact pathway was genuinely communicated.

ALL YES Standard likely met. ANY PARTIAL Improvement plan required. ANY NO Blocks accreditation until resolved.

REFERENCES

1. [103] Professional interpreter use is consistently associated with improved comprehension, informed consent quality, and clinical outcomes compared with ad hoc interpretation by untrained bilingual staff or family members.

Language access for medical tourism carries the same stakes as language access anywhere else in care, with one added complication: the patient has no established relationship with the local health system to fall back on if communication fails. Genuine interpreter competency, not improvised bilingual staff, is what this actually requires.

1 A trained interpreter is used for the main consultation but not for aftercare instructions at discharge.

Aftercare instructions carry real, ongoing risk if misunderstood after the patient has left.

2 Interpreter access exists but isn't confirmed until the patient has already arrived.

Advance confirmation avoids a scramble that risks falling back on ad hoc arrangements.

3 Interpretation occurs but understanding is never actively checked afterward.

Interpretation without verified understanding doesn't confirm the communication actually worked.

Week 1 Review current interpreter arrangements for international patients.

Week 2 Establish advance booking of trained interpreters matched to expected patient languages.

Week 3 Extend interpreter use explicitly to aftercare instruction, not only initial consultation.

Ongoing Spot-check patient understanding after interpreted consultations.

Ask specifically about aftercare instruction interpretation, not just the main consultation.

This is where interpreter use most commonly lapses.

Ask a patient to explain back their own aftercare instructions.

This tests genuine understanding, not just that an interpreter was present.

ALL YES Standard likely met. ANY PARTIAL Improvement plan required. ANY NO Requires improvement plan.

REFERENCES

1. [104] Patient-reported experience research in medical tourism consistently identifies logistical coordination, not clinical quality alone, as a major determinant of overall satisfaction and perceived safety.

A patient recovering from a procedure in an unfamiliar country, without local language fluency or a support network, faces real logistical risk beyond the clinical care itself. Genuine coordination support — not just a list of nearby hotels — reduces stress that can itself affect recovery.

1 Coordination support is offered for the arrival but not for the return journey.

Logistics risk doesn't end once the procedure itself is complete.

2 Accommodation recommendations exist but aren't verified for genuine recovery suitability.

A recommendation that hasn't been checked may not actually suit a recovering patient's needs.

3 A contact exists but isn't clearly communicated or reachable outside office hours.

Logistics problems can arise at any time, not only during business hours.

Week 1 Review current logistics support against genuine coordination versus informational lists.

Week 2 Verify recommended accommodation options for genuine recovery suitability.

Week 3 Establish a specific, reachable logistics contact for the duration of the stay.

Ongoing Gather patient feedback on logistics coordination quality.

Ask a recent international patient how logistics support actually worked in practice.

Real experience reveals more than a description of intended coordination.

Ask what happens if a logistics problem arises outside office hours.

This reveals whether support is genuinely continuous, not just during standard hours.

ALL YES Standard likely met. ANY PARTIAL Improvement plan required. ANY NO Blocks accreditation until resolved.

REFERENCES

1. [105] Post-operative complication tracking following international medical travel is identified in the medical tourism literature as a systemic gap, with most facilities lacking any mechanism to learn about complications that surface after the patient has returned home.

This is one of the biggest gaps in medical tourism practice generally: accountability effectively ends the moment the patient boards their flight home. A complication discovered weeks later by a home physician almost never makes it back to the facility that performed the original procedure, which means the facility never learns from outcomes it should be learning from.

1 Follow-up happens once but isn't repeated if the patient doesn't respond the first time.

A single missed attempt shouldn't end the tracking process for a real complication risk.

2 A reporting pathway exists but isn't communicated to the patient or their home provider.

An unknown pathway provides no real function.

3 Complications are recorded but never reviewed collectively for patterns.

Individual records without pattern review miss the systemic learning this tracking is meant to provide.

Week 1 Review current post-return follow-up practice for structure versus a single generic attempt.

Week 2 Establish a specific pathway for home-country physicians to report complications.

Week 3 Build a process for reviewing tracked outcomes and feeding findings into practice.

Ongoing Track complication rates and review for patterns periodically.

Ask for a real example of a complication learned about after a patient returned home.

A real example, or its honest absence, reveals whether tracking genuinely functions.

Ask how a home-country physician would actually reach this facility to report a concern.

A specific, confident answer reveals a genuine pathway, not an assumed one.

ALL YES Standard likely met. ANY PARTIAL Improvement plan required. ANY NO Requires improvement plan.

REFERENCES

1. [106] Medical travel facilitation literature identifies documentation delays and errors as a leading cause of care-seeking delay for international patients, with downstream clinical consequences for time-sensitive conditions.

Visa and immigration requirements for medical travel are specific and vary by country, and a delayed or incorrect document can derail a patient's ability to travel for care at all, sometimes with real clinical urgency behind the delay. This is a logistics function, but one with real clinical consequences when it fails.

1 Documentation is generally correct but not verified against the specific requirements of every relevant country.

Requirements genuinely vary by country, and a generic approach risks missing country-specific needs.

2 Lead time is adequate for common cases but not for countries with longer processing times.

Processing time varies significantly by country, and lead time should reflect the patient's actual situation.

3 A correction process exists but isn't clearly known to staff handling these requests.

An unfamiliar process functions poorly under real time pressure.

Week 1 Review current visa documentation practice for accuracy and lead time.

Week 2 Establish country-specific documentation checklists for common patient origins.

Week 3 Establish a specific, responsive correction process for documentation errors.

Ongoing Track visa-related delays and adjust lead time practice accordingly.

Ask for a real example of documentation provided for a specific country's requirements.

A real, specific example reveals genuine accuracy, not a generic template.

Ask what happens when a documentation error is discovered close to a travel date.

This reveals whether the correction process is genuinely responsive under real pressure.

ALL YES Standard likely met. ANY PARTIAL Improvement plan required. ANY NO Blocks accreditation until resolved.

REFERENCES

1. [107] Cross-border patient redress mechanisms are identified in international medical travel governance literature as a distinct requirement from domestic complaint processes, given the specific access barriers international patients face after returning home.

A complaint channel that requires being physically present, or fluent in the local language, or navigating an unfamiliar system from abroad effectively excludes exactly the patients most likely to need it — those who have already returned home when a real problem becomes apparent.

1 A remote complaint channel exists but response times are significantly slower than for local complaints.

A technically accessible channel that responds too slowly doesn't provide genuine redress.

2 The channel is accessible by email but not genuinely responsive to patients writing in other languages.

Technical accessibility without genuine language responsiveness doesn't achieve real access.

3 Complaints are received but resolution isn't consistently documented or communicated back to the patient.

An undocumented or uncommunicated resolution provides little real reassurance to the patient.

Week 1 Review current complaint channel for genuine remote and language accessibility.

Week 2 Establish or strengthen remote-accessible complaint intake in relevant languages.

Week 3 Establish documented resolution tracking with communication back to the patient.

Ongoing Track response times and resolution rates for international patient complaints specifically.

Ask for a real example of a complaint received from a patient after they had already returned home.

A real example reveals whether the channel genuinely functions for exactly the patients who need it most.

Test the complaint channel's accessibility in a language other than the local one.

This directly reveals genuine language accessibility, not an assumption of it.

ALL YES Standard likely met. ANY PARTIAL Improvement plan required. ANY NO Blocks accreditation until resolved.

REFERENCES

1. [108] Medical tourism governance literature consistently identifies unregulated facilitator and agent networks as a distinct risk category, separate from the clinical quality of the treating facility itself.

Medical tourism facilitators sit between the patient and the facility with real influence over what the patient is told and expects, and an unverified facilitator can misrepresent risks, costs, or outcomes in ways the facility only discovers after a patient arrives already misinformed.

1 Verification happens for new facilitator relationships but isn't reconfirmed for long-standing ones.

A facilitator's legitimacy and practices can change over time even after an initial, valid verification.

2 Verification covers business registration but not the accuracy of their patient-facing representations.

A legitimately registered facilitator can still misrepresent risks or outcomes to patients.

3 Patients occasionally arrive with expectations that don't match what the facility actually offers.

This is a real, observable signal that facilitator representation review deserves closer attention.

Week 1 Review current facilitator relationships for specific verification versus assumed legitimacy.

Week 2 Establish or strengthen documented verification for every facilitator relationship.

Week 3 Build a periodic reconfirmation schedule and a process for reviewing facilitator representations.

Ongoing Review patient expectations against facility reality as an indicator of facilitator accuracy.

Ask for the actual verification record for a specific, named facilitator.

A specific, documented record is the real evidence of genuine verification, not assumed legitimacy.

Ask a recent international patient what they were told by their facilitator before arrival.

This reveals whether facilitator representations actually match facility reality.

ALL YES Standard likely met. ANY PARTIAL Improvement plan required. ANY NO Blocks accreditation until resolved.

REFERENCES

1. [109] Travel-associated antimicrobial resistance and infection risk is a documented, distinct category in infection prevention literature, with international medical travel specifically identified as a transmission risk pathway requiring targeted screening protocols.

International patients carry different exposure histories, and in some cases different antimicrobial resistance profiles, than the local population. A generic infection control approach that doesn't account for this misses a real, specific, and well-documented risk category unique to cross-border care.

1 The assessment happens for surgical procedures but not consistently for other invasive procedures.

Travel-associated infection risk applies to any procedure carrying genuine infection exposure, not surgery alone.

2 Country of origin is recorded but not specifically used to inform the risk assessment.

Recorded information that doesn't inform the actual assessment provides no real protective value.

3 Precautions are identified but application is inconsistent across different staff.

Consistent application across everyone involved is what gives the precautions real protective value.

Week 1 Review current intake practice for a specific travel-associated infection risk step.

Week 2 Build a structured assessment reflecting country of origin and travel history.

Week 3 Establish consistent application of indicated precautions across all staff.

Ongoing Audit assessment completion and precaution application for international patients.

Ask to see the specific travel-associated risk assessment for a recent international patient.

A specific, real example reveals whether this is genuine practice, not just a policy statement.

Ask staff how the assessment differs for patients from different countries of origin.

A specific, informed answer reveals genuine understanding, not a generic infection-control response.

ALL YES Standard likely met. ANY PARTIAL Improvement plan required. ANY NO Blocks accreditation until resolved.

REFERENCES

1. [110] Established international travel health guidance recommends against air travel for 10-14 days following major surgery given the combined risk of surgery and air travel for blood clots, including deep vein thrombosis and pulmonary embolism.

Air travel and surgery each independently increase blood clot risk, and combining them within an unsafe window is a genuine, documented danger specific to medical tourism — a patient who travelled specifically for this procedure has an obvious incentive to fly home as soon as they feel able, which is exactly why this needs to be an explicit conversation, not an assumption.

1 The discussion happens for major procedures but is abbreviated for shorter or perceived lower-risk ones.

Even shorter procedures combined with long-haul travel carry genuine, documented risk.

2 Timing is mentioned but the specific reasoning behind it isn't explained.

Understanding why matters for a patient weighing their own travel decision against the recommendation.

3 The discussion happens but isn't documented, relying on staff memory that it occurred.

Undocumented discussion is difficult to distinguish from a discussion that didn't happen.

Week 1 Review current practice for specific, documented travel timing discussion.

Week 2 Build a specific, procedure-appropriate travel timing script into pre-departure counselling.

Week 3 Establish documentation confirming the discussion occurred for every international patient.

Ongoing Spot-check patient understanding of their specific recommended timing.

Ask an international patient directly what they were told about travel timing.

This tests actual understanding, not just that a conversation is assumed to have occurred.

Check documentation for a shorter, perceived lower-risk procedure specifically.

This is where the discussion most commonly gets abbreviated or skipped.